acquired
Stage
About
Forma Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutics for rare hematologic diseases and cancers. The company was acquired by Novo Nordisk in 2022.
Explore Forma Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.